The side effects of any medication are going to impact how long a person stays with their course of treatment, says De Jonghe
Cells 2023;12:2009.ArticlePubMedPMC 17
Regular follow-ups allow us to track progress, provide accountability, and adjust your plan as needed
Ortinski, P
Key Takeaway GHK-Cu stands out as a rare compound with documented ability to reactivate pigment pathways in hair follicles, offering hope not only for reversing early graying but also for delaying its onset
Timeline of Key Regulatory and Legal Events: September 9, 2025 FDA Warning Letter: The FDA issued a warning letter to Hims & Hers Health on September 9, 2025, finding false or misleading claims on its website about compounded semaglutide and tirzepatide, including phrases such as Same active ingredient as Ozempic and Wegovy and Clinically proven ingredients, which imply the compounded products are the same as FDA-approved drugs when they are not